Commonwealth Equity Services
GNMK

Commonwealth Equity Services’s GenMark Diagnostics, Inc GNMK Stock Holding History

Commonwealth Equity Services’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,237
Closed -$150K – 3150
2020
Q2 		$150K Sell
10,237
-35,950
-78% -$365K ﹤0.01% 2699
2020
Q1 		$190K Buy
46,187
+12,487
+37% +$58.5K ﹤0.01% 2417
2019
Q4 		$162K Buy
33,700
+12,000
+55% +$66.2K ﹤0.01% 2668
2019
Q3 		$131K Buy
21,700
+3,700
+21% +$23.1K ﹤0.01% 2638
2019
Q2 		$116K Buy
18,000
+1,000
+6% +$7.05K ﹤0.01% 2620
2019
Q1 		$120K Buy
17,000
+1,000
+6% +$6.59K ﹤0.01% 2578
2018
Q4 		$77K Buy
16,000
+2,000
+14% +$10.4K ﹤0.01% 2528
2018
Q3 		$102K Sell
14,000
-4,000
-22% -$29.3K ﹤0.01% 2639
2018
Q2 		$115K Buy
+18,000
New +$119K ﹤0.01% 2585

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Commonwealth Equity Services's GNMK Position: Q3 2020 in Review

Commonwealth Equity Services sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2020, closing a stake of 10,237 shares — an estimated $150K sold.

Commonwealth Equity Services first reported a position in GNMK in Q2 2018 and held it in 9 quarters. The position peaked at $190K in Q1 2020. 163 funds tracked by Wall St. Rank hold GNMK as of Q3 2020.

  • Commonwealth Equity Services reported no remaining GenMark Diagnostics, Inc position as of Q3 2020 after selling out during the quarter.
  • Commonwealth Equity Services sold 10,237 GenMark Diagnostics, Inc shares in Q3 2020, an estimated $150K.
  • Commonwealth Equity Services first reported a position in GenMark Diagnostics, Inc in Q2 2018 and held it in 9 quarters.
  • Commonwealth Equity Services's GenMark Diagnostics, Inc position peaked at $190K in Q1 2020.
  • 163 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2020.

Based on Commonwealth Equity Services's 13F filing for Q3 2020, filed 5 Nov 2020.